Parker Waichman LLP

“Disease Mongering” Behind Blockbuster Requip Sales

Restless Legs Syndrome (RLS) is a relatively new term that has become somewhat ubiquitous following a multi-million dollar ad campaign spearheaded by drug maker GlaxoSmithKline.  Given that the US Food and Drug Administration (FDA) has approved generic versions of Requip, RLS may have run its course, according to experts. In 2005, the FDA approved the […]

Restless Legs Syndrome (RLS) is a relatively new term that has become somewhat ubiquitous following a multi-million dollar ad campaign spearheaded by drug maker GlaxoSmithKline.  Given that the US Food and Drug Administration (FDA) has approved generic versions of <"https://www.yourlawyer.com/topics/overview/requip">Requip, RLS may have run its course, according to experts.

In 2005, the FDA approved the first drug for RLS—a twitching condition affecting the legs—launching a new household term, a new designer disorder, and a multi-million-dollar consumer ad campaign.  Television ads hyping ropinirole hydrochloride, a drug originally used to treat Parkinson’s disease, sent patients to doctors demanding brand name, Requip.  In under a year, Requip sales doubled from $165 million in 2005 to nearly $330 million in 2006.  By last year, 4.4 million prescriptions were written, with sales of nearly $491 million, according to IMS health, an industry information agency.

Some call the RLS phenomenon an example of “disease mongering” in which promoters, such as drug companies, deliberately enlarge the market by promoting advertisement and convincing people they’re sick and need treatment.  “You may have something that’s a normal condition,” said Dr. Lisa M. Schwartz, associate professor of medicine and community and family medicine at Dartmouth Medical School in Hanover, New Hampshire.  “It makes you wonder whether there’s a disease to be treated.”  Schwartz and her husband, Dr. Steven Woloshin, also at Dartmouth, say that drug company promotions, combined with uncritical media reporting, exaggerated the prevalence of RLS, leading to over-diagnosis and -treatment with powerful brain-altering drugs.

At least one sleep disorder specialist expects the focus on RLS to fade as rapidly as the Requip television commercials, which have been pulled.  “Restless legs syndrome is a great example of a suddenly out-of-the-blue disease,” said Dr. Christopher J. Earley, an associate professor of neurology at Johns Hopkins University in Baltimore who treats RLS.  Advertising created an overheated demand for diagnosis among consumers, while samples gave and easy answer for busy doctors, he said.  “I would anticipate there would be something of a fall-off,” Earley said.

That prediction alarms patient advocates who welcomed public attention—and all that drug industry funding; however, the generic switch leads to fewer ads, that should decrease patient demand for diagnosis and treatment, leaving only the most serious sufferers to weigh the benefits against potentially severe side effects.  Doctors may not be inclined to prescribe the drug if the supply of brand-name samples disappears; generics won’t come with samples.

Ad decline depends largely on the makers of Mirapex, the second-leading drug approved to treat RLS, said Schwartz.  “If it ends up that they pull back, the market might go down,” Schwartz said.  “It’s usually a pretty sharp drop,” said Glaxo spokeswoman Mary Anne Rhyne.

Though drugmakers portrayed their products as a sure-fire cure for symptoms, the reality isn’t so certain.   The range varied considerably in the trials, none of which lasted more than 12 weeks.

And, side effects can be considerable.  The biggest problems included debilitating nausea, dizziness, and falling asleep during daily activities and studies link the  drugs to compulsions such as gambling or sexual promiscuity.  Even when the drugs do work, patients face problems of increased tolerance, which can cause augmentation, in which the drug increases RLS symptoms.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Edward Mooney
6 years ago
5 Star Reviews 150
Thank you for your help Cristian, you are doing a very good job.
L Puj
2 months ago
5 Star Reviews 150
Thank you Michelle Josama at Parker and waichman for being so great from day one with my family and myself! It was a pleasure meeting and working with you! Thank you for your care and professionalism.
bfst6611 st
4 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038